MedPath

Traditional Chinese medicine regulating body and preventing disease based on TCM constitution: A demonstration study of Covid-19 prevention for key populations (Anti-epidemic Special No.: 2022011)

Phase 1
Not yet recruiting
Conditions
Biased constitution (Qi deficiency and phlegm-dampness)
Registration Number
ITMCTR2200006544
Lead Sponsor
Beijing University of Chinese Medicine Shenzhen Hospital(Longgang)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Key populations of Shenzhen's epidemic prevention (such as transportation personnel, Big supermarkets, and medical institution staff), who have a negative COVID-19 nucleic acid test and have completed the whole course of the Covid-19 vaccination; (2) Men or women aged 18-60; (3) Those who have a phlegm-dampness constitution or a Qi-deficiency constitution after being identified by a professional TCM doctor.

Exclusion Criteria

(1) Severe systemic diseases (malignant tumors, autoimmune diseases, liver and kidney diseases) or surgical operations (splenectomy, organ transplantation); (2) Pregnant or lactating women; (3) Participate in other clinical trials within three months; ?Allergic to the research drug; ? With other constitutions; ? Other conditions judged by the investigators.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Ā© 2025 MedPath, Inc. All rights reserved.